Market Forecast News: United States Bioresorbable Vascular Scaffolds Market insights, Future outlook | Top Companies - BIOTRONIK, REVA Medical, Arterius

"Global Bioresorbable Vascular Scaffolds Market is expected to reach at a high CAGR during the forecast period 2024-2031." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/bioresorbable-vascular-scaffolds-market?sp

United States: Recent Industry Developments

✅ In November 2025, Abbott Laboratories launched a next-generation bioresorbable vascular scaffold in the U.S., designed for coronary artery disease patients, providing temporary vessel support and gradual resorption to reduce long-term complications. The scaffold integrates improved polymer composition for enhanced flexibility and safety. It reinforces Abbott's leadership in interventional cardiology and innovative cardiovascular devices.

✅ In October 2025, Boston Scientific introduced a bioresorbable scaffold system with enhanced radial strength and drug-elution technology for complex coronary lesions, targeting high-risk patient populations. The platform supports improved clinical outcomes and minimizes restenosis. It highlights U.S. innovation in advanced scaffold technologies.

✅ In September 2025, Medtronic initiated a clinical trial for a next-generation bioresorbable scaffold combining bioresorbable polymer with anti-proliferative drug coating, aiming to improve long-term vessel patency and reduce thrombosis risk. The trial involves multiple U.S. cardiology centers. It demonstrates U.S. commitment to safer and more effective coronary interventions.

✅ In August 2025, Terumo Medical Corporation (U.S. operations) expanded its BVS portfolio with flexible, thin-strut scaffolds suitable for tortuous coronary anatomy, offering improved deliverability and resorption rates. The scaffolds aim to enhance patient safety and procedural success. It underscores U.S. investment in next-generation cardiovascular device innovation.

Japan: Recent Industry Developments

✅ In November 2025, Terumo Corporation launched a bioresorbable vascular scaffold for coronary artery interventions in Japanese hospitals, featuring thin-strut polymer design and controlled drug release to minimize restenosis. The device supports safe and effective vessel remodeling. It reflects Japan's focus on advanced interventional cardiology technologies.

✅ In October 2025, Nipro Corporation introduced a next-generation BVS for coronary lesions, combining bioresorbable polymers with anti-proliferative coatings to reduce thrombosis risk and improve long-term vessel function. The product targets complex patient populations in Japan. It demonstrates Japan's investment in innovative scaffold solutions.

✅ In September 2025, Terumo Cardiovascular Systems Japan initiated a clinical trial for a bioresorbable scaffold system with enhanced flexibility and drug-elution capabilities for treating coronary artery disease. The study evaluates safety, efficacy, and resorption profiles. It highlights Japan's commitment to evidence-based cardiovascular innovation.

✅ In August 2025, Kaneka Corporation expanded its cardiovascular device portfolio with a bioresorbable scaffold optimized for minimal strut thickness and improved deliverability, targeting tortuous coronary anatomy and high-risk patients. The product enhances procedural safety and long-term outcomes. It underscores Japan's focus on advanced coronary intervention technologies.

Bioresorbable Vascular Scaffolds Market: Drivers

The bioresorbable vascular scaffolds (BVS) market is witnessing growth due to increasing prevalence of cardiovascular diseases and the demand for advanced coronary interventions. BVS devices provide temporary support to blocked arteries and gradually dissolve, reducing long-term complications associated with permanent stents. Rising adoption of minimally invasive procedures and patient preference for solutions that restore natural vessel function are driving market demand. Technological advancements in scaffold materials, such as polymer and magnesium-based compositions, are enhancing safety, efficacy, and bioresorption rates. Additionally, growing awareness among cardiologists and patients about the benefits of next-generation vascular therapies is supporting market expansion.

Research and development efforts focused on improving mechanical strength, flexibility, and drug-eluting properties are further fueling innovation in the BVS market. Collaborations between medical device manufacturers and healthcare providers are accelerating clinical trials and regulatory approvals. Increasing investment in cardiovascular healthcare infrastructure and rising accessibility in emerging regions are enhancing market penetration. Awareness campaigns emphasizing early intervention and long-term patient outcomes are also encouraging adoption. With continuous technological advancements and growing emphasis on patient-centric cardiovascular care, the bioresorbable vascular scaffolds market is poised for sustained growth globally.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/bioresorbable-vascular-scaffolds-market?sp

Bioresorbable Vascular Scaffolds Market: Major Players

BIOTRONIK, REVA Medical, Arterius, Meril Life Sciences Pvt. Ltd, Zorion Medical, Translumina, Abbott, Boston Scientific Corporation, Nano Therapeutics, Tsuna Med and among others.

Segment Covered in the Bioresorbable Vascular Scaffolds Market:

By Device Type
Bioresorbable vascular scaffolds are segmented into Everolimus-eluting Devices, Novolimus-eluting Devices, and Sirolimus-eluting Devices. Sirolimus-eluting devices lead the market owing to their superior biocompatibility, controlled drug release, and proven efficacy in reducing restenosis rates.

By Application
Applications include Coronary Artery Disease and Peripheral Artery Disease. Coronary artery disease holds the dominant share due to the high global prevalence of cardiovascular disorders and the increasing adoption of bioresorbable scaffolds as an alternative to traditional stents.

By Material Type
Based on material, the market is divided into Poly-L-Lactic Acid (PLLA), Tyrosine-derived Polycarbonate, and Others. PLLA-based scaffolds account for the largest share as they offer excellent mechanical strength, biocompatibility, and gradual degradation within the body.

By End User
End users comprise Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Labs, and Others. Hospitals dominate the market owing to advanced cardiac care facilities, skilled professionals, and the growing number of interventional cardiovascular procedures.

Research Process:

Both primary and secondary data sources have been used in the Bioresorbable Vascular Scaffolds Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Bioresorbable Vascular Scaffolds Market Research Industry:

➠ Who leads the Bioresorbable Vascular Scaffolds industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Bioresorbable Vascular Scaffolds market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Bioresorbable Vascular Scaffolds market growth?
➠ What are the dominant sales and distribution strategies in the Bioresorbable Vascular Scaffolds industry?

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=bioresorbable-vascular-scaffolds-market
(Purchase 2 or more Repots and get 50% Discount)

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.